AGRN and muscular dystrophy: However, we did not observe any defects in agrin's level, molecular size, or its capacity to bind α‐dystroglycan in our patient muscles, strongly suggesting that impaired agrin glycosylation cannot explain the muscular dystrophy in our patients.